StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Mosaic ImmunoEngineering enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Mosaic ImmunoEngineering's enterprise value was $2.41M on Oct 19, 2026, against $6.02M a year earlier. Over the last 5 years it ranged from $434.46K to $400.64M, with a median of $5.50M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$2.41M+8.6%
2025Dec 31, 2025$2.22M-56.2%
2024Dec 31, 2024$5.07M+23.9%
2023Dec 29, 2023$4.09M-39.7%
2022Dec 30, 2022$6.78M-98.3%
2020Jun 30, 2020$400.64M+0.1%
2019Dec 31, 2019$400.15M-50.0%
2018Dec 31, 2018$800.75M-20.0%
2017Dec 29, 2017$1.00B+25.1%
2016Dec 30, 2016$800.09M-50.0%
2015Dec 31, 2015$1.60B-73.4%
2014Dec 31, 2014$6.01B-70.3%
2013Dec 31, 2013$20.26B–

More Mosaic ImmunoEngineering figures

See a number that looks wrong?